Ranked by engagement
Top topics — all time page 4
Ranked by replies, likes and views over all time, with a bonus for topics that reached a marked solution. Engagement is a proxy for usefulness and a poor one; the documentation commons is the better index of what is settled.
1,535 topics · page 4 of 40
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Promotion criteria, and the one that stops most nominations — the long version
On the subject in the title: Promotion criteria, and the one that stops most nominations — the long version Working notes rather than a conclusion. A narrow question about Promotion criteria, deliberately…
|
+130 | 143 | 7.2k | 6mo |
|
Revisiting: The report format the maintainers ask for, and why each field is there
Posting this under the heading it deserves: Revisiting: The report format the maintainers ask for, and why each field is there Everything below is what sits behind that. Structured report rather than an…
|
+100 | 108 | 57k | 1d |
|
[2026 update] Storing lyophilised material long term: what governs the shelf life
Storing lyophilised material long term: what governs the shelf life — setting out what I have, and where I think it stops being reliable. Two things I would like separated before anyone answers on Storing…
|
+122 | 133 | 35k | 1mo |
|
Vomiting: when it is expected and when it is a reason to stop
Posting this under the heading it deserves: Vomiting: when it is expected and when it is a reason to stop Everything below is what sits behind that. Reporting something rather than asking about it, in case…
|
+116 | 124 | 43k | 7mo |
|
A field-by-field walk through a certificate of analysis
Posting this under the heading it deserves: A field-by-field walk through a certificate of analysis Everything below is what sits behind that. I have spent a fortnight trying to pin field-by-field walk…
|
+136 | 147 | 1.8k | 12mo |
|
Scheduled maintenance and what will be unavailable
Scheduled maintenance and what will be unavailable Writing it up because I had to work it out twice and would rather nobody else did. Collecting what is known about scheduled maintenance in one place, because…
|
+120 | 128 | 25k | 15mo |
|
Second pass at: Retatrutide dose escalation in the published trials
Second pass at: Retatrutide dose escalation in the published trials — setting out what I have, and where I think it stops being reliable. Two things I would like separated before anyone answers on Retatrutide…
|
+115 | 125 | 30k | 2y |
|
Alcohol: what is documented and what is folklore
Posting this under the heading it deserves: Alcohol: what is documented and what is folklore Everything below is what sits behind that. Alcohol, and specifically the version of it that the documentation does…
|
+120 | 134 | 11k | 2d |
|
Follow-up: Tirzepatide's shorter half-life and its one practical consequence
Tirzepatide's shorter half-life and its one practical consequence Writing it up because I had to work it out twice and would rather nobody else did. Documentation question rather than a pharmacological one,…
|
+130 | 137 | 11k | 19mo |
|
Second pass at: Sodium, potassium and magnesium when intake drops
Second pass at: Sodium, potassium and magnesium when intake drops Writing it up because I had to work it out twice and would rather nobody else did. A hydration and intake question, with the figures, since…
|
+132 | 142 | 12k | 22mo |
|
Tracking a shortage from primary sources rather than rumour
Tracking a shortage from primary sources rather than rumour — setting out what I have, and where I think it stops being reliable. An honest uncertainty about tracking a shortage rather than a disguised…
|
+121 | 126 | 35k | 13h |
|
Half-life, steady state, and accumulation worked through
Half-life, steady state, and accumulation worked through Writing it up because I had to work it out twice and would rather nobody else did. Working through the kinetics rather than the pharmacology, because I…
|
+115 | 130 | 44k | 13mo |
|
Validating a calculator against hand arithmetic — what changed since
Posting this under the heading it deserves: Validating a calculator against hand arithmetic — what changed since Everything below is what sits behind that. What changes if the standard account of Validating a…
|
+121 | 137 | 21k | 13mo |
|
A parcel that arrived warm: a decision process, not a verdict
A parcel that arrived warm: a decision process, not a verdict Writing it up because I had to work it out twice and would rather nobody else did. Asking about the failure mode rather than the procedure,…
|
+130 | 140 | 12k | 8mo |
|
A 5 mg vial and a 0.25 mg dose: the arithmetic in full
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Writing it up because I had to work it out twice and would rather nobody else did. 5 mg vial: setting out the arithmetic in full, because I have had to…
|
+124 | 141 | 16k | 2d |
|
Reading an MS report that only gives you a single number
On the subject in the title: Reading an MS report that only gives you a single number Working notes rather than a conclusion. I would like to understand what this number means before I repeat it anywhere. A…
|
+100 | 113 | 48k | 13mo |
|
Follow-up: What other technical communities get right that we do not
What other technical communities get right that we do not I have a specific reason for asking rather than idle curiosity, and the context is below. A digression I have been saving for the right category. It…
|
+117 | 126 | 13k | 14mo |
|
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters
On the subject in the title: 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Working notes rather than a conclusion. A follow-up question about 0.3 ml versus 0.5 ml that I did not know to ask the…
|
+108 | 124 | 27k | 2mo |
|
The 2.5 mg starting dose is not a therapeutic dose — why that matters
The 2.5 mg starting dose is not a therapeutic dose — why that matters Writing it up because I had to work it out twice and would rather nobody else did. A follow-up question about 2.5 mg starting dose that I…
|
+119 | 136 | 5.6k | 2mo |
|
Insurance and replacement policies, compared
On the subject in the title: Insurance and replacement policies, compared Working notes rather than a conclusion. I have spent a fortnight trying to pin insurance and replacement policies down and I want to…
|
+115 | 122 | 17k | 17h |
|
Revisiting: How to bring a laboratory report to an appointment usefully
Revisiting: How to bring a laboratory report to an appointment usefully — setting out what I have, and where I think it stops being reliable. Asking about bring a laboratory directly, because I have read four…
|
+143 | 154 | 1.7k | 21mo |
|
New subcategory: rationale and scope
On the subject in the title: New subcategory: rationale and scope Working notes rather than a conclusion. Proposing that new subcategory deserves a maintained page rather than a recurring topic, and drafting…
|
+123 | 138 | 13k | 9mo |
|
Specification in the result column: why that is a meaningful error
Posting this under the heading it deserves: Specification in the result column: why that is a meaningful error Everything below is what sits behind that. A documentation question rather than an analytical…
|
+107 | 129 | 41k | 5mo |
|
Second pass at: Cross-border purchase within the EU: the actual rules
Posting this under the heading it deserves: Second pass at: Cross-border purchase within the EU: the actual rules Everything below is what sits behind that. The question about Cross-border purchase within…
|
+135 | 139 | 8.7k | 16mo |
|
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version
Posting this under the heading it deserves: Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Everything below is what sits behind that. I have read the maintained page…
|
+138 | 148 | 1.8k | 2y |
|
Grapefruit: why this class is not the class that cares
Grapefruit: why this class is not the class that cares Writing it up because I had to work it out twice and would rather nobody else did. I was wrong about grapefruit in a thread last spring and I would like…
|
+126 | 139 | 4k | 4mo |
|
Journal club: orforglipron phase 2 and the non-peptide question
Journal club: orforglipron phase 2 and the non-peptide question Writing it up because I had to work it out twice and would rather nobody else did. Orforglipron phase 2, and specifically the version of it that…
|
+120 | 132 | 13k | 1d |
|
Hypertension improvement and when medication needs revisiting — a second dataset
Posting this under the heading it deserves: Hypertension improvement and when medication needs revisiting — a second dataset Everything below is what sits behind that. Posting a small dataset on Hypertension…
|
+126 | 133 | 22k | 21mo |
|
Reading a home test result without over-claiming
Reading a home test result without over-claiming — setting out what I have, and where I think it stops being reliable. Collecting what is known about reading a home test result in one place, because it is…
|
+124 | 137 | 19k | 7h |
|
Coming back to: Washout: how long is long enough, and for what purpose
Posting this under the heading it deserves: Washout: how long is long enough, and for what purpose Everything below is what sits behind that. A narrow question about Washout, deliberately narrow, because the…
|
+128 | 139 | 3k | 3mo |